These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 19935713
1. Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis. Peuhu E, Rivero-Müller A, Stykki H, Torvaldson E, Holmbom T, Eklund P, Unkila M, Sjöholm R, Eriksson JE. Oncogene; 2010 Feb 11; 29(6):898-908. PubMed ID: 19935713 [Abstract] [Full Text] [Related]
2. The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling. Peuhu E, Paul P, Remes M, Holmbom T, Eklund P, Sjöholm R, Eriksson JE. Biochem Pharmacol; 2013 Sep 01; 86(5):571-83. PubMed ID: 23747345 [Abstract] [Full Text] [Related]
3. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway. Pespeni MH, Hodnett M, Abayasiriwardana KS, Roux J, Howard M, Broaddus VC, Pittet JF. Cancer Res; 2007 Mar 15; 67(6):2865-71. PubMed ID: 17363610 [Abstract] [Full Text] [Related]
4. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T. Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419 [Abstract] [Full Text] [Related]
5. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells. Zhang X, Li W, Olumi AF. Clin Cancer Res; 2007 Dec 01; 13(23):7181-90. PubMed ID: 18056199 [Abstract] [Full Text] [Related]
6. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M. Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347 [Abstract] [Full Text] [Related]
7. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand. Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T. Mol Cancer Res; 2008 Dec 07; 6(12):1852-60. PubMed ID: 19074830 [Abstract] [Full Text] [Related]
8. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. Kim YH, Lee YJ. J Cell Biochem; 2007 Mar 01; 100(4):998-1009. PubMed ID: 17031854 [Abstract] [Full Text] [Related]
9. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639 [Abstract] [Full Text] [Related]
10. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. Choi WY, Jin CY, Han MH, Kim GY, Kim ND, Lee WH, Kim SK, Choi YH. Anticancer Res; 2009 Nov 15; 29(11):4457-65. PubMed ID: 20032392 [Abstract] [Full Text] [Related]
11. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP. Kang J, Bu J, Hao Y, Chen F. Prostate Cancer Prostatic Dis; 2005 Nov 15; 8(3):274-9. PubMed ID: 15897917 [Abstract] [Full Text] [Related]
12. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S, Mukhtar H. Oncogene; 2008 Mar 27; 27(14):2055-63. PubMed ID: 17998943 [Abstract] [Full Text] [Related]
13. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R, Bedi A. Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014 [Abstract] [Full Text] [Related]
14. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells. Sun SY, Yue P, Lotan R. Oncogene; 2000 Sep 14; 19(39):4513-22. PubMed ID: 11002424 [Abstract] [Full Text] [Related]
15. PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells. Kadowaki Y, Chari NS, Teo AE, Hashi A, Spurgers KB, McDonnell TJ. Apoptosis; 2011 Jun 14; 16(6):627-35. PubMed ID: 21437722 [Abstract] [Full Text] [Related]
16. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
17. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression. Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B. Oncogene; 2004 Jun 24; 23(29):4993-5003. PubMed ID: 15048072 [Abstract] [Full Text] [Related]
18. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. Lee DH, Szczepanski MJ, Lee YJ. J Cell Biochem; 2009 Apr 15; 106(6):1113-22. PubMed ID: 19229860 [Abstract] [Full Text] [Related]
19. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ. Oncol Rep; 2007 Jan 15; 17(1):175-84. PubMed ID: 17143496 [Abstract] [Full Text] [Related]
20. Sensitization of human K562 leukemic cells to TRAIL-induced apoptosis by inhibiting the DNA-PKcs/Akt-mediated cell survival pathway. Kim MJ, Kim HB, Bae JH, Lee JW, Park SJ, Kim DW, Park SI, Kang CD, Kim SH. Biochem Pharmacol; 2009 Sep 15; 78(6):573-82. PubMed ID: 19464267 [Abstract] [Full Text] [Related] Page: [Next] [New Search]